Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients
Authors
Keywords
-
Journal
Cancer Biomarkers
Volume 21, Issue 2, Pages 335-343
Publisher
IOS Press
Online
2017-11-22
DOI
10.3233/cbm-170472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-218 inhibits the tumorgenesis and proliferation of glioma cells by targeting Robo1
- (2016) Jian-Jun Gu et al. Cancer Biomarkers
- Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma
- (2016) Bin-Hui Xie et al. Cancer Biomarkers
- miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase
- (2016) Moustafa Sakr et al. GENE
- Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma
- (2016) Amit Ghosh et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion
- (2016) Yang Li et al. MOLECULAR NEUROBIOLOGY
- Prognostic value of microRNA-126 and CRK expression in gastric cancer
- (2016) Shun Yue et al. OncoTargets and Therapy
- Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer
- (2015) H. Okabe et al. ANNALS OF SURGICAL ONCOLOGY
- Predictive and Prognostic Markers in the Treatment of Metastatic Colorectal Cancer (mCRC)
- (2015) Sebastian Stintzing et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Towards a molecular understanding of microRNA-mediated gene silencing
- (2015) Stefanie Jonas et al. NATURE REVIEWS GENETICS
- Overexpression of miR-126 Inhibits the Activation and Migration of HSCs through Targeting CRK
- (2014) Xu-Hua Gong et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Low expression of MicroRNA-126 is associated with poor prognosis in colorectal cancer
- (2014) Yaling Liu et al. GENES CHROMOSOMES & CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Increased MicroRNA-630 Expression in Gastric Cancer Is Associated with Poor Overall Survival
- (2014) Dake Chu et al. PLoS One
- Poor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph Nodes
- (2013) Toru Kusano et al. ANNALS OF SURGICAL ONCOLOGY
- miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A
- (2012) X. Zhu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- miR-126 functions as a tumour suppressor in human gastric cancer
- (2010) Runhua Feng et al. CANCER LETTERS
- The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer
- (2010) Kari Chansky et al. Journal of Thoracic Oncology
- The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3
- (2010) Hui Wang et al. TUMOR BIOLOGY
- The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
- (2008) Shusheng Wang et al. DEVELOPMENTAL CELL
- Endogenous human microRNAs that suppress breast cancer metastasis
- (2008) Sohail F. Tavazoie et al. NATURE
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started